Skip to main content

INVESTING IN INNOVATION

Commercialising world class research from UCL

£0M

HAS been invested in UCL projects

0

Proof of concept investments

0

Spinouts

0

Licensing projects

AstronauTx secures UCLTF investment for dementia therapeutics

Achilles Therapeutics raises £100m in Series B

UCL engineering cancer antibody therapies for Covid-19

Epsilogen Announces £3m Series A2 financing and licences MOv18 IgE, an anti-folate receptor alpha IgE antibody from King’s College London

Why we Invested in Quantum Computing start-up Phasecraft

Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment